Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Returned to the company President & C.E.O. returned 27,022 shares (to the company)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Returned to the company President & C.E.O. returned 34,095 shares (to the company)
  4. 4 Returned to the company President Crescendo BioScience returned 9,297 shares (to the company)
  5. 4 Returned to the company President Myriad RBM, Inc. returned 5,609 shares (to the company)
  6. 4 Returned to the company President Assurex Health Inc. returned 5,794 shares (to the company)
  7. 4 Returned to the company Exec. VP International Ops returned 6,321 shares (to the company)
  8. 4 Returned to the company E.V.P., General Counsel returned 820 shares (to the company)
  9. 4 Returned to the company President, MGL returned 1,269 shares (to the company)
  10. 4 Returned to the company President, MWH returned 11,920 shares (to the company)
  11. 4 Returned to the company Chief Scientific Officer returned 9,758 shares (to the company)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Returned to the company Chief Financial Officer returned 11,920 shares (to the company)
  14. 5 Insider Annual Insider Trading Report
  15. 4 Open-market sale President & C.E.O. sold 137,000 shares at $44.00 ($6,028,000)
  16. 4 Open-market sale Exec. VP International Ops sold 60,000 shares at an average $43.49 ($2,609,329)
  17. 4 Open-market sale President Crescendo BioScience sold 11,712 shares at $40.00 ($468,480)
  18. 4 Open-market sale Chief Financial Officer sold 25,000 shares at $41.50 ($1,037,575)
  19. 3 Insider Initial Statement of Ownership
  20. 5 Insider Annual Insider Trading Report

Page 24 of 65 · 1,294 filings